Fondazione Italiana Linfomi - Ets

This study tests a daily pill called pirtobrutinib in elderly patients (70+) with mantle cell lymphoma who are too frail for standard chemotherapy. The drug targets a specific protein to control the cancer. Patients will take the pill until the disease worsens or side effects bec…

This study looks at whether people with early-stage Hodgkin lymphoma who respond well to two cycles of chemotherapy can safely receive a lower dose of radiation (20 Gy instead of the usual 30 Gy). About 518 adults will take part. The goal is to see if the lower dose works just as…

This study tests a drug called glofitamab in 41 people with mantle cell lymphoma whose cancer did not respond or came back after CAR T-cell therapy. The goal is to see if glofitamab can shrink or eliminate tumors. Participants receive the drug and are monitored for response and s…

This study compares a geriatric-guided care approach, which includes nutritional and rehabilitation support, to standard cancer treatment alone in elderly patients (70+) with diffuse large B-cell lymphoma. The goal is to see if this personalized plan improves quality of life and …

This study looks at how well the drug combination BV-CHP works in real life for people with a rare type of lymphoma called systemic Anaplastic Large Cell Lymphoma (sALCL). Researchers will collect medical records and tumor samples from 100 patients to see how the treatment affect…

This study follows 100 adults with certain types of lymphoma who are receiving CAR-T cell therapy. Researchers will test thinking, memory, and quality of life before treatment and again at 6, 12, and 24 months after. The goal is to understand how the therapy affects brain functio…